Archives of Toxicology

, Volume 64, Issue 3, pp 210–217

Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats

Physicochemical and biochemical factors involved
  • W. S. Beck
  • H. T. Schneider
  • K. Dietzel
  • B. Nuernberg
  • K. Brune
Original Articles


Aspirin, diclofenac, diflunisal, ibuprofen and indomethacin were given orally or intravenously to fasted or fed rats. The resulting gastric and intestinal damage was assessed using standard methods. The same drugs were administered to rats with biliary fitulas, and the fraction of drug excreted in bile was quantified using HPLC methods. We found that gastric damage occurred only in the fasted animals and was found to be dose-dependent and related to the amount (r=0.871) and solubility (r=0.909) of the individual drug. As far as acute gastric toxicity is concerned, neither the potency of a drug as an inhibitor of cyclo-oxygenase nor the fraction of unchanged or conjugated agent excreted in bile appeared to be relevant. Secondly, ulcerations of the small intestine occurred in fed animals only. The degree of damage was related to the amount of unchanged or conjugated drug excreted in bile and cyclo-oxygenase inhibitory potency (r=0.873). The administered dose (within the range investigated) and drug solubility appeared not to contribute to intestinal toxicity. It is concluded that, in the rat, acute gastric and intestinal toxicity of non-steroidal anti-inflammatory drugs are due to different mechanisms. Whereas gastric toxicity is strongly influenced by the amount of drug dissolved under the pH conditions in the stomach, intestinal toxicity appears to depend on biliary excretion and enterohepatic circulation of a drug as well as on its potency as an inhibitor of prostaglandin synthesis.

Key words

Aspirin Diclofenac Diflunisal Ibuprofen Indomethacin Non-steroidal anti-inflammatory agents Gastrointestinal toxicity Prostaglandins Biliary excretion 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amick EN, Mason WD (1979) Determination of aspirin, salicylic acid, salicyluric acid, and gentisic acid in human plasma and urine by high pressure liquid chromatography. Anal Lett 12(B6): 629–640Google Scholar
  2. Beermann B (1985) Peptic ulcers induced by piroxicam. Br Med J 290: 789Google Scholar
  3. Bollmann JL (1948) A cage which limits the activity of rats. J Lab Clin Md 33: 1348Google Scholar
  4. Brodie DA, Hooke KF (1971) Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate. Am J Dig Dis 16: 985–989PubMedGoogle Scholar
  5. Brune K (1987) Pharmakologische Kenndaten als Basis einer Differentialtherapie mit nicht-steroidalen Anti-phlogistika. Z Rheumatol 46: 13–18PubMedGoogle Scholar
  6. Brune K, Lanz R (1985) Pharmacokinetics of non-steroidal antiinflammatory drugs. In: Bonta IL, Bray MA, Parnham MJ (eds) Handbook of inflammation, Vol 5. Elsevier, Amsterdam, pp 413–449Google Scholar
  7. Brune K, Glatt M, Kaelin H, Peskar BA (1978) Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 274: 261–263PubMedGoogle Scholar
  8. Brune K, Rainsford KD, Wagner K, Peskar BA (1981) Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Factors influencing the apparent drug effects. Naunyn-Schmiedeberg's Arch Pharmacol 315: 269–276Google Scholar
  9. Brune K, Dietzel K, Nuernberg B, Schneider HT (1987 a) Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl 65: 135–140PubMedGoogle Scholar
  10. Brune K, Nuernberg B, Szelenyi I, Vergin H (1987 b) The enterohepatic circulation of some anti-inflammatory drugs may cause intestinal ulcerations. In: Rainsford KD, Velo GP (eds) Side-effects of anti-inflammatory drugs, Part two: Studies in major organ systems. MTP Press, Lancaster, pp 29–37Google Scholar
  11. Collier DSJ, Pain JA (1985) Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26: 359–363PubMedGoogle Scholar
  12. Davenport HW (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med 276: 1307–1312PubMedGoogle Scholar
  13. Duggan DE, Hooke KF, Noll RM, Kwan KC (1975) Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 25: 1749–1754Google Scholar
  14. Fenner H, Mixich G (1973) NMR studies of the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation. Arzneim Forsch (Drug Res) 23(5): 667–669Google Scholar
  15. Fini A, Laus M, Orienti I, Zecchi V (1986) Dissolution and partition thermodynamic functions of some anti-inflammatory drugs. J Pharm Sci 75(1): 23–25PubMedGoogle Scholar
  16. Geisslinger G, Dietzel K, Loew D, Schuster O, Rau G, Lachmann G, Brune K (1989) High-performance liquid Chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr 491: 139–149PubMedGoogle Scholar
  17. Godbillon J, Gauron S, Metayer JP (1985) High-performance liquid Chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J Chromatogr 338: 151–159PubMedGoogle Scholar
  18. Herzfeldt CD, Kuemmel R (1983) Dissociation constants, solubilities and dissolution rates of some selected non-steroidal anti-inflammatories. Drug Dev Ind Pharm 9(5): 767–793Google Scholar
  19. Hoftiezer JW, Burks M, Silvoso GR, Ivey KJ (1980) Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet ii: 609–612Google Scholar
  20. Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE (1976) Kinetics of indometacin absorption, elimination and enterohepatic circulation in man. J Pharmacol Biopharm 4: 255–280Google Scholar
  21. Langman MJS, Morgan L, Worrall A (1985) Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 290: 347–349Google Scholar
  22. Lanza FL (1984) Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other non-steroidal anti-inflammatory agents. Am J Med Jul 13: 19–24Google Scholar
  23. Laufen H, Leitold M, Riedel KD (1984) The effect of activated charcoal on the gastrointestinal absorption and reabsorption of piroxicam in dog and man. In: Abstracts, 2nd European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, p 356Google Scholar
  24. Levy M, Miller DR, Kaufman DW, Siskind V, Schwingl P, Rosenberg L, Strom B, Shapiro S (1988) Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other non-narcotic analgesics. Arch Int Med 148: 281–285Google Scholar
  25. Martin BK (1963) Accumulation of drug anions in gastric mucosal cells. Nature 198: 896–897Google Scholar
  26. McCormack K, Brune K (1987) Classical absorption theory and the development of gastric mucosal damage associated with the nonsteroidal anti-inflammatory drugs. Arch Toxicol 60: 261–269PubMedGoogle Scholar
  27. Menasse R, Hedwall PR, Kraitz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R (1978) Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol Suppl 22: 5–16PubMedGoogle Scholar
  28. Moeller N, Dietzel K, Schneider HT, Brune K (1989) Novel 5-aminosalicylic acid NSAID conjugates: synthesis, pharmacological and toxicological properties. Eur J Med Chem 24: 463–469Google Scholar
  29. Nielsen-Kudsk F (1980) HPLC-determination of some antiinflammatory, weak analgesics and uricosuric drugs in human blood plasma and its application to pharmacokinetics. Acta Pharmacol Toxicol 47: 267–273Google Scholar
  30. Nuernberg B, Brune K (1986) Analyse der biliären Elimination eines nicht-steroidalen Antirheumatikums (Diflunisal) bei Mensch und Hund. Akt Rheumatol 11: 116 -120Google Scholar
  31. Paulus HE (1985) FDA Arthritis Advisory Committee Meeting: Postmarketing surveillance of non-steroidal anti-inflammatory drugs. Arth Rheum 28(10): 1168–1169Google Scholar
  32. Paumgartner G, Horak W, Probst P, Grabner G (1971) Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 270: 98–101Google Scholar
  33. Peskar BA, Steffens C, Peskar BM (1979) Radioimmunoassay of 6-ketoprostaglandin F1α in biological material. In: Albertini A, Da Prada M, Peskar BA (eds) Radioimmunoassay of drugs and hormones in cardiovascular medicine. Elsevier, Amsterdam, pp 239–250Google Scholar
  34. Pfeiffer CJ, Lewandowski LG (1971) Comparison of gastric toxicity of acetylsalicylic acid with route of administration in the rat. Arch Int Pharmacodyn 190: 5–13PubMedGoogle Scholar
  35. Rainsford KD (1982) An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 2: 1–10PubMedGoogle Scholar
  36. Rainsford KD, Brune K (1978) Selective cytotoxic actions of aspirin on parietal cells: a principal factor in the early stages of aspirin-induced gastric damage. Arch Toxicol 40(2): 143–150PubMedGoogle Scholar
  37. Rossi AC, Hsu JP, Faich GA (1987) Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. Br Med J 294: 147Google Scholar
  38. Schneider HT, Nuernberg B, Dietzel K, Brune K (1990) Biliary elimination of non-steroidal anti-inflammatory drugs in patients. Br J Clin Pharmacol 29: 127–131PubMedGoogle Scholar
  39. Shen TY (1981) Toward more selective anti-arthritic therapy. J Med Chem 24(1): 1–5PubMedGoogle Scholar
  40. Shen TY, Winter CA (1977) Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 12: 89–245Google Scholar
  41. Smith PC, Benet LZ (1984) High-performance liquid Chromatographic method for the determination of indomethacin and its two primary metabolites in urine. J Chromatogr 306: 315–321PubMedGoogle Scholar
  42. Somerville K, Faulkner G, Langman M (1986) Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet i: 462–464Google Scholar
  43. St John DJB (1975) Gastric mucosal damage by aspirin. CRC Crit Rev Toxicol June 1975: 317–344Google Scholar
  44. Walt R, Katschinski B, Logan R, Ashley J, Langman M (1986) Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet i: 489–492Google Scholar
  45. Whittle BJR (1981) Arachidonic acid metabolites and the gastrointestinal toxicity of anti-inflammatory agents. Prostaglandins Suppl 21: 113–118Google Scholar
  46. Yesair DW, Callahan M, Remington L, Kensler CJ (1970) Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem Pharmacol 19: 1579–1590PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • W. S. Beck
    • 1
  • H. T. Schneider
    • 2
  • K. Dietzel
    • 3
  • B. Nuernberg
    • 4
  • K. Brune
    • 1
  1. 1.Department of Pharmacology and ToxicologyUniversity of Erlangen-NürnbergErlangenFederal Republic of Germany
  2. 2.Department of Internal Medicine IUniversity of Erlangen-NürnbergErlangenFederal Republic of Germany
  3. 3.College of Pharmacy, Department of PharmaceuticsUniversity of Florida, JHMHCGainsvilleUSA
  4. 4.Department of RheumatologyRoyal North Shore Hospital, University of SydneySt. LeonardsAustralia

Personalised recommendations